Viemed Healthcare, Inc. (NASDAQ:VMD) Short Interest Down 12.5% in June

Viemed Healthcare, Inc. (NASDAQ:VMD) was the target of a large decline in short interest in June. As of June 15th, there was short interest totalling 273,600 shares, a decline of 12.5% from the May 31st total of 312,800 shares. Based on an average daily trading volume, of 142,400 shares, the days-to-cover ratio is presently 1.9 days. Approximately 0.8% of the shares of the stock are sold short.

Institutional Trading of Viemed Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in VMD. Vanguard Group Inc. raised its holdings in Viemed Healthcare by 53.0% in the 1st quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company’s stock worth $16,803,000 after purchasing an additional 617,009 shares during the period. Kent Lake Capital LLC acquired a new stake in shares of Viemed Healthcare in the first quarter valued at $5,557,000. Bard Associates Inc. raised its stake in shares of Viemed Healthcare by 882.0% in the fourth quarter. Bard Associates Inc. now owns 338,335 shares of the company’s stock valued at $2,656,000 after acquiring an additional 303,880 shares in the last quarter. Essex Investment Management Co. LLC raised its stake in shares of Viemed Healthcare by 1.5% in the first quarter. Essex Investment Management Co. LLC now owns 250,109 shares of the company’s stock valued at $2,359,000 after acquiring an additional 3,776 shares in the last quarter. Finally, Millrace Asset Group Inc. purchased a new position in Viemed Healthcare in the fourth quarter valued at $1,458,000. Institutional investors and hedge funds own 74.24% of the company’s stock.

Viemed Healthcare Stock Performance

NASDAQ VMD opened at $6.55 on Friday. The stock has a market capitalization of $254.27 million, a PE ratio of 25.19 and a beta of 1.49. The business has a 50 day simple moving average of $7.25 and a two-hundred day simple moving average of $8.02. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.28 and a quick ratio of 1.14. Viemed Healthcare has a 1-year low of $5.90 and a 1-year high of $10.44.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings data on Monday, May 6th. The company reported $0.04 EPS for the quarter. Viemed Healthcare had a return on equity of 9.32% and a net margin of 5.32%. The company had revenue of $50.59 million for the quarter.

Analyst Ratings Changes

Separately, Lake Street Capital raised Viemed Healthcare to a “strong-buy” rating in a research note on Tuesday, May 7th.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.